Insights into the Roles of Epigenetic Modifications in Ferroptosis

Jinghua Kong,Hao Lyu,Qian Ouyang,Hao Shi,Rui Zhang,Shuai Xiao,Dong Guo,Qi Zhang,Xing-Zhen Chen,Cefan Zhou,Jingfeng Tang

DOI: https://doi.org/10.3390/biology13020122

2024-02-16

Biology

Abstract:Ferroptosis is a non-apoptotic mode of cell death driven by membrane lipid peroxidation and is characterized by elevated intracellular levels of Fe2+, ROS, and lipid peroxidation. Studies have shown that ferroptosis is related to the development of multiple diseases, such as cancer, neurodegenerative diseases, and acute myeloid leukemia. Ferroptosis plays a dual role in the occurrence and development of these diseases. Ferroptosis mainly involves iron metabolism, ROS, and lipid metabolism. Various mechanisms, including epigenetic regulation, have been reported to be deeply involved in ferroptosis. Abnormal epigenetic modifications have been reported to promote tumor onset or other diseases and resistance to chemotherapy drugs. In recent years, diversified studies have shown that epigenetic modification is involved in ferroptosis. In this review, we reviewed the current resistance system of ferroptosis and the research progress of epigenetic modification, such as DNA methylation, RNA methylation, non-coding RNAs, and histone modification in cancer and other diseases by regulating ferroptosis.

biology

What problem does this paper attempt to address?

The paper aims to explore the role of epigenetic modifications in ferroptosis. Ferroptosis is a non-apoptotic mode of cell death that is closely related to the occurrence and development of various diseases, such as cancer, neurodegenerative diseases, and acute myeloid leukemia. Specifically, the main objectives of this review paper include:

1. **Overview of the ferroptosis resistance system**: Introduces the current understanding of the ferroptosis resistance system, particularly the research progress in areas such as DNA methylation, RNA methylation, non-coding RNA, and histone modifications.

2. **Role of epigenetic modifications**: Discusses in detail how epigenetic modifications influence the progression of cancer and other diseases by regulating ferroptosis. For example, the specific mechanisms of DNA methylation, RNA methylation, and non-coding RNA in ferroptosis.

3. **Identification of new biomarkers and therapeutic strategies**: Summarizes the targets of epigenetic modification regulation of ferroptosis, which helps to discover new prognostic indicators for human diseases and provides potential therapeutic strategies for these diseases.

Through these studies, the authors hope to provide new insights into diseases related to ferroptosis and offer a theoretical basis for clinical treatment.